{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T16:05:50Z","timestamp":1792944350709,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.tice.2022.101877","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T21:59:40Z","timestamp":1659045580000},"page":"101877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Olmesartan ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats via Nrf2\/HO-1 signaling pathway"],"prefix":"10.1016","volume":"78","author":[{"given":"Begad Mohamed","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed Shahat","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim Ghalib","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama Mohamed","family":"Abo-Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Sayed Mohamed","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tice.2022.101877_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jbt.21494","article-title":"Uroprotective effect of pentoxifylline in cyclophosphamide-induced hemorrhagic cystitis in rats","volume":"27","author":"Abo-Salem","year":"2013","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tice.2022.101877_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/607246","article-title":"Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue","volume":"2014","author":"Al-Harbi","year":"2014","journal-title":"BioMed. Res. Int."},{"issue":"2","key":"10.1016\/j.tice.2022.101877_bib3","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1078155220920690","article-title":"Incidence of hemorrhagic cystitis after cyclosphamide therapy with or without mesna: a cohort study and comprehensive literature review","volume":"27","author":"Almalag","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"issue":"4","key":"10.1016\/j.tice.2022.101877_bib4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1139\/cjpp-2019-0299","article-title":"Protective effects of olmesartan and L-carnitine on doxorubicin-induced cardiotoxicity in rats","volume":"98","author":"Aziz","year":"2020","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.tice.2022.101877_bib5","series-title":"Theory and practice of histological techniques","first-page":"117","author":"Banchroft","year":"1996"},{"key":"10.1016\/j.tice.2022.101877_bib6","series-title":"CRC Handbook of Methods for Oxygen Radical Research","first-page":"283","article-title":"Catalase activity","author":"Clairborne","year":"1985"},{"issue":"1","key":"10.1016\/j.tice.2022.101877_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1590\/S0102-86502010000100011","article-title":"Protective effect of simvastatin in the cyclophosphamide-induced hemohrragic cystitis in rats","volume":"25","author":"Dantas","year":"2010","journal-title":"Acta Cir. Bras."},{"key":"10.1016\/j.tice.2022.101877_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CMAR.S186696","article-title":"Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-\u03baB signaling pathways","volume":"11","author":"El-Agamy","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"5","key":"10.1016\/j.tice.2022.101877_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.pharep.2017.03.020","article-title":"Anti-inflammatory and anti-arthritic properties of naringenin via attenuation of NF-\u03baB and activation of the hemeoxygenase.(HO).-1\/related factor 2 pathway","volume":"69","author":"Fan","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.tice.2022.101877_bib10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1248\/bpb.b16-00296","article-title":"Olmesartan prevented intra-articular inflammation induced by zymosan in rats","volume":"39","author":"Guerra","year":"2016","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.tice.2022.101877_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbt.22889","article-title":"Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR-4\/NF-\u03baB, and JAK1\/STAT3 signaling in cyclophosphamide-intoxicated rats","volume":"35","author":"Hassanein","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tice.2022.101877_bib12","unstructured":"Kabel, A.M., Elkhoely, A.A., 2017. Amelior. Eff. Coenzyme Q10 \/ Or. candesartan carboplatin-Induc. Nephrotox.: roles apoptosis, Transform. Growth Factor-\u03921, Nucl. Factor kappa-B Nrf2 \/ HO-1 Pathw., 18, 16, pp. 1629\u20131636."},{"issue":"6","key":"10.1016\/j.tice.2022.101877_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10157-015-1111-5","article-title":"Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury","volume":"19","author":"Kadowaki","year":"2015","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.tice.2022.101877_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.fct.2013.11.023","article-title":"Mechanism for the protective effect of diallyl disulfide against cyclophosphamide acute urotoxicity in rats","volume":"64","author":"Kim","year":"2014","journal-title":"Food Chem. Toxicol."},{"issue":"5","key":"10.1016\/j.tice.2022.101877_bib15","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10565-006-0078-0","article-title":"Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; Implication of reactive oxygen and nitrogen species as well as PARP activation","volume":"23","author":"Korkmaz","year":"2007","journal-title":"Cell Biol. Toxicol."},{"issue":"7","key":"10.1016\/j.tice.2022.101877_bib16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.bjp.0707323","article-title":"Molecularcharacterisation of the interactions between olmesartan and telmisartan and the hyman andiotensin II AT1 receptor","volume":"151","author":"Le","year":"2007","journal-title":"Br. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.tice.2022.101877_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0027-5107(85)90216-7","article-title":"Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB\/c mice","volume":"148","author":"Marklund","year":"1985","journal-title":"Mutat. Res."},{"issue":"2019","key":"10.1016\/j.tice.2022.101877_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.vph.2019.01.004","article-title":"Angiotensin II and vascular damage in hypertension: Role of oxidative stress and sympathetic activation","volume":"115","author":"Masi","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.tice.2022.101877_bib19","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.urology.2016.07.030","article-title":"Review of advances in uroprotective gents for cyclophosphamide and ifosfamide-induced hemorrhagic cystitis","volume":"100","author":"Matz","year":"2017","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.tice.2022.101877_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox10030349","article-title":"Nrf2 signaling pathway in chemoprotection and doxorubicin resistance: potential application in drug discovery","volume":"10","author":"Mirzaei","year":"2021","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.tice.2022.101877_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.taap.2013.04.026","article-title":"Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats","volume":"271","author":"Nagib","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tice.2022.101877_bib22","series-title":"Guide for the Care and Use of Laboratory Animals","author":"National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"issue":"2","key":"10.1016\/j.tice.2022.101877_bib23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj0940705","article-title":"A Colorimetric micro-method for the determination of glutathione","volume":"94","author":"owens","year":"1965","journal-title":"J. Biochem"},{"key":"10.1016\/j.tice.2022.101877_bib24","doi-asserted-by":"crossref","unstructured":"H. Pan\u00a0et al., 2012.Absence Nrf2 Enhanc. NF- \u03ba B-Depend. Inflamm. Scratch Inj. Mouse Prim. Cult. Astro, pp. 1\u20139.","DOI":"10.1155\/2012\/217580"},{"key":"10.1016\/j.tice.2022.101877_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2018.12.020","article-title":"Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NF \u03ba B and Nrf-2 \/ HO-1 signaling crosstalk","volume":"364","author":"Saber","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"11","key":"10.1016\/j.tice.2022.101877_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s11095-021-03126-5","article-title":"Olmesartan niosomes ameliorates the Indomethacin-induced gastric ulcer in rats: Insights on MAPK and Nrf2\/HO-1 signaling pathway","volume":"38","author":"Sallam","year":"2021","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.tice.2022.101877_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/cbf.2978","article-title":"Protective effects of lipoic acid and mesna on cyclophosphamide-induced haemorrhagic cystitis in mice","volume":"32","author":"Song","year":"2014","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.tice.2022.101877_bib28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1600-079X.2004.00202.x","article-title":"Melatonin ameliorates bladder damage induced by cyclophosphamide in rats","volume":"38","author":"Topal","year":"2005","journal-title":"J. Pineal Res."},{"issue":"4","key":"10.1016\/j.tice.2022.101877_bib29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-079X.2010.00756.x","article-title":"Effect of melatonin on the expression of Nrf2 and NF-\u03baB during cyclophosphamide-induced urinary bladder injury in rat","volume":"48","author":"Tripathi","year":"2010","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.tice.2022.101877_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","article-title":"Determination of malonaldehyde precursor in tissues by thiobarbituric acid test","volume":"86","author":"Uchiyama","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tice.2022.101877_bib31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/136.Supplement_2.S311","article-title":"Enzyme-linked immunosorbent assay for hepatitis B surface antigen","volume":"136","author":"Wolters","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.tice.2022.101877_bib32","first-page":"1","article-title":"Polysaccharides from hemp seed protect against cyclophosphamide-induced intestinal oxidative damage via Nrf2-Keap1 signaling pathway in mice","volume":"2020","author":"Xue","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"11","key":"10.1016\/j.tice.2022.101877_bib33","first-page":"1","article-title":"Edaravone attenuated particulate matter-induced lung inflammation by inhibiting ROS- NF-\u03baB signaling pathway","volume":"35","author":"Zeng","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2021","key":"10.1016\/j.tice.2022.101877_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2021.06.023","article-title":"Activation of Nrf2\/HO-1 signaling: an important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress","volume":"34","author":"Zhang","year":"2021","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.tice.2022.101877_bib35","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.2147\/DDDT.S217826","article-title":"Olmesartan medoxomil, an angiotensin II-receptor blocker, ameliorates renal injury in db\/db mice","volume":"13","author":"Zhu","year":"2019","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622001495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816622001495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:23:11Z","timestamp":1758572591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816622001495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":35,"alternative-id":["S0040816622001495"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2022.101877","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olmesartan ameliorates cyclophosphamide-induced hemorrhagic cystitis in rats via Nrf2\/HO-1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2022.101877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101877"}}